VR Logo

Vincerx Pharma Inc. (VINC) download report


Healthcare | Biotechnology & Pharma Research

Vincerx Pharma Inc. (VINC) Premium Coverage

52 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Vincerx Pharma, Inc., a clinical-stage biopharmaceutical company, researches and develops therapies to address unmet medical needs for the treatment of cancer in the United States.

IPO Date: 27-May-2020

Founder, Chairman & CEO: Dr. Ahmed M. Hamdy M.D.

Founder, Gen. Counsel & Chief Legal Officer: Mr. Tom C. Thomas J.D.

Listing: NASDAQ: VINC

Country: United States

Headquarters: Palo Alto, CA

Website: https://vincerx.com

Key Facts

Market cap: $27.80 Mln

Revenue (TTM): $0.00 Mln

Earnings (TTM): $-49.45 Mln

Cash: $96.49 Mln

Total Debt: $0.85 Mln

Insider's Holding: 28.65%

Liquidity: Low

52 Week range: $1.27 - 18.43

Shares outstanding: 21,057,600

Stock Performance

Time Period Vincerx Pharma (VINC) S&P BSE Sensex S&P Small-Cap 600
YTD-86.36-8.71-17.92
1 month-15.24-3.11-7.88
3 months-67.22-7.30-13.56
1 Year-87.940.48-17.16
3 Years--10.346.95
5 Years--11.436.30
10 Years--12.1010.29
As on 28-Jun-2022
Year Vincerx Pharma (VINC) S&P Small-Cap 600 S&P BSE Sensex
2021-51.2725.2721.99